08/07/2025 Adagene and ConjugateBio sign a partnership agreement to develop novel ADC (Ref) Adagene announced a partnership with ConjugateBio to provide a proprietary antibody for use in partner companies’ bispecific ADC development programs Under the terms of the agreement, Adagene will receive an undisclosed upfront payment, as well as milestone and royalty payments Adagene will provide an internally developed antibody for novel bispecific ADC development Adagene retains al